Client News
Marinomed Biotech AG Reports Significant Revenue Growth for the First 9 Months 2021
EsoCap secures new funding
InflaRx to Present at H.C. Wainwright 7th Annual Israel Conference
Secarna Pharmaceuticals and Achilles Therapeutics sign research, option and license agreement to develop optimized T cell therapies
MagForce AG: MagForce USA, Inc. has Received FDA’s Approval to Proceed with Stage 2B with the Final Protocol of the Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System
InflaRx Reports Third Quarter 2021 Financial & Operating Results
HepaRegeniX to present key results on MKK4 inhibitors and their therapeutic efficacy at upcoming scientific conferences
Imcyse Appoints Gene Mack, MBA as Chief Financial Officer
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development